{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T02:40:11Z","timestamp":1754016011988,"version":"3.41.2"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022544","name":"Samsung Biomedical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["31484"],"award-info":[{"award-number":["31484"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.seizure.2024.05.010","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T03:15:37Z","timestamp":1715829337000},"page":"25-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Efficacy and tolerability of levetiracetam in people with and without intellectual disabilities: A naturalistic case control study"],"prefix":"10.1016","volume":"120","author":[{"given":"Jon","family":"Allard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Sellers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6273-2619","authenticated-orcid":false,"given":"William","family":"Henley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1419-8540","authenticated-orcid":false,"given":"Brendan","family":"McLean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Parrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9286-7696","authenticated-orcid":false,"given":"Sanjeev","family":"Rajakulendran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lance","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Ellawela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phil","family":"Tittensor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliet","family":"Bransgrove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjune","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiv","family":"Mohanraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2712-8499","authenticated-orcid":false,"given":"Many","family":"Bagary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Ram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1687-1644","authenticated-orcid":false,"given":"Nathan","family":"Vernon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandy","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagdish","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1183-6933","authenticated-orcid":false,"given":"Rohit","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2024.05.010_bib0001","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.seizure.2015.03.016","article-title":"Prevalence of epilepsy among people with intellectual disabilities: a systematic review","volume":"29","author":"Robertson","year":"2015","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.seizure.2024.05.010_bib0002","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1212\/WNL.0000000000003509","article-title":"Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies","volume":"88","author":"Fiest","year":"2017","journal-title":"Neurology"},{"journal-title":"NHS Digital","article-title":"Health and care of people with learning disabilities: experimental statistics: 2017-2018","year":"2019","key":"10.1016\/j.seizure.2024.05.010_bib0003"},{"year":"1992","series-title":"International Classification of Diseases 10th Revision","key":"10.1016\/j.seizure.2024.05.010_bib0004"},{"issue":"5","key":"10.1016\/j.seizure.2024.05.010_bib0005","first-page":"13","article-title":"Epilepsy in intellectual disabilities","volume":"13","author":"Ring","year":"2013","journal-title":"Adv Clin Neurosci Rehabil"},{"key":"10.1016\/j.seizure.2024.05.010_bib0006","unstructured":"National Institute for Health and Care Excellence. Epilepsies in children, young people and adults. NG217. 2022."},{"key":"10.1016\/j.seizure.2024.05.010_bib0007","unstructured":"Royal College of Psychiatrist. Prescribing anti-epileptic drugs for people with epilepsy and intellectual disability (CR206). 2017."},{"issue":"2","key":"10.1016\/j.seizure.2024.05.010_bib0008","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/14656566.2019.1695780","article-title":"Quality improvement in the management of people with epilepsy and intellectual disability: the development of clinical guidance","volume":"21","author":"Watkins","year":"2020","journal-title":"Expert Opin Pharmacother"},{"issue":"Suppl 1","key":"10.1016\/j.seizure.2024.05.010_bib0009","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1528-1157.2001.00515.x","article-title":"Evidence-based prescribing in adults with learning disability and epilepsy","volume":"42","author":"Kerr","year":"2001","journal-title":"Epilepsia"},{"issue":"Pt 2","key":"10.1016\/j.seizure.2024.05.010_bib0010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2788.2007.01025.x","article-title":"A general practice-based prevalence study of epilepsy among adults with intellectual disabilities and of its association with psychiatric disorder, behaviour disturbance and carer stress","volume":"52","author":"Matthews","year":"2008","journal-title":"J Intellect Disabil Res"},{"issue":"Suppl 1","key":"10.1016\/j.seizure.2024.05.010_bib0011","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/jar.12386","article-title":"Management and prevalence of long-term conditions in primary health care for adults with intellectual disabilities compared with the general population: A population-based cohort study","volume":"31","author":"Cooper","year":"2018","journal-title":"Journal of applied research in intellectual disabilities : JARID"},{"key":"10.1016\/j.seizure.2024.05.010_bib0012","unstructured":"Glover G., Evison F. Hospital admissions that should not happen: admissions for ambulatory care sensitive conditions for people with learning disabilities in England. Improving Health and Lives 2013."},{"issue":"6","key":"10.1016\/j.seizure.2024.05.010_bib0013","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/jir.12047","article-title":"Mortality from sudden unexpected death in epilepsy (SUDEP) in a cohort of adults with intellectual disability","volume":"58","author":"Kiani","year":"2014","journal-title":"J Intellect Disabil Res"},{"key":"10.1016\/j.seizure.2024.05.010_bib0014","unstructured":"Glover G., Ayub M. How People With Learning Disabilities Die 2010."},{"key":"10.1016\/j.seizure.2024.05.010_bib0015","doi-asserted-by":"crossref","first-page":"106192","DOI":"10.1016\/j.eplepsyres.2019.106192","article-title":"Epilepsy-related and other causes of mortality in people with epilepsy: A systematic review of systematic reviews","volume":"157","author":"Mbizvo","year":"2019","journal-title":"Epilepsy Res"},{"issue":"4","key":"10.1016\/j.seizure.2024.05.010_bib0016","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.seizure.2008.10.009","article-title":"How is epilepsy treated in people with a learning disability? A retrospective observational study of 183 individuals","volume":"18","author":"Ring","year":"2009","journal-title":"Seizure"},{"issue":"6","key":"10.1016\/j.seizure.2024.05.010_bib0017","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.seizure.2003.10.002","article-title":"Epilepsy in the United Kingdom: seizure frequency and severity, anti-epileptic drug utilization and impact on life in 1652 people with epilepsy","volume":"13","author":"Moran","year":"2004","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.seizure.2024.05.010_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jar.12228","article-title":"Service responses to people with intellectual disabilities and epilepsy: A systematic review","volume":"30","author":"Robertson","year":"2017","journal-title":"J Appl Res Intellect Disabil"},{"key":"10.1016\/j.seizure.2024.05.010_bib0019","doi-asserted-by":"crossref","first-page":"108191","DOI":"10.1016\/j.yebeh.2021.108191","article-title":"The relationship between antiepileptic drug load and challenging behaviors in older adults with intellectual disability and epilepsy","volume":"122","author":"Monaghan","year":"2021","journal-title":"Epilepsy Behav\u202f: E&B"},{"key":"10.1016\/j.seizure.2024.05.010_bib0020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.seizure.2011.12.012","article-title":"Factors influencing the costs of epilepsy in adults with an intellectual disability","volume":"21","author":"Pennington","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2024.05.010_bib0021","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.seizure.2010.10.030","article-title":"The misdiagnosis of epilepsy in people with intellectual disabilities: a systematic review","volume":"20","author":"Chapman","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2024.05.010_bib0022","first-page":"CD005399","article-title":"Pharmacological interventions for epilepsy in people with intellectual disabilities","author":"Jackson","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.seizure.2024.05.010_bib0023","unstructured":"WHO. ICD-11: international classification of diseases (11th revision) 2022. https:\/\/icd.who.int\/ (accessed 2023)."},{"key":"10.1016\/j.seizure.2024.05.010_bib0024","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ridd.2010.12.018","article-title":"Prevalence of intellectual disability: a meta-analysis of population-based studies","volume":"32","author":"Maulik","year":"2011","journal-title":"Res Dev Disabil"},{"key":"10.1016\/j.seizure.2024.05.010_bib0025","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1212\/WNL.0000000000002060","article-title":"Delivery of epilepsy care to adults with intellectual and developmental disabilities","volume":"85","author":"Devinsky","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2024.05.010_bib0026","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/ene.13016","article-title":"Managing anti-epileptic drug treatment in adult patients with intellectual disability: a serious conundrum","volume":"23","author":"Doran","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.seizure.2024.05.010_bib0027","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.seizure.2017.05.012","article-title":"Perampanel in the general population and in people with intellectual disability: differing responses","volume":"49","author":"Shankar","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2024.05.010_bib0028","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/ane.13368","article-title":"Eslicarbazepine acetate response in intellectual disability population versus general population","volume":"143","author":"Allard","year":"2021","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2024.05.010_bib0029","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.seizure.2020.02.013","article-title":"Lacosamide in the general population and in people with intellectual disability: similar responses?","volume":"76","author":"Allard","year":"2020","journal-title":"Seizure"},{"issue":"11","key":"10.1016\/j.seizure.2024.05.010_bib0030","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3390\/brainsci11111452","article-title":"Comparative efficacy of levetiracetam for epilepsy in school-aged children with intellectual disability and normal intelligence","volume":"11","author":"Moon","year":"2021","journal-title":"Brain Sci"},{"key":"10.1016\/j.seizure.2024.05.010_bib0031","unstructured":"NICE. British National Formulary (online). NICE; 2022. https:\/\/bnf.nice.org.uk\/drugs\/levetiracetam\/."},{"key":"10.1016\/j.seizure.2024.05.010_bib0032","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fneur.2013.00192","article-title":"Clinical pharmacology and pharmacokinetics of levetiracetam","volume":"4","author":"Wright","year":"2013","journal-title":"Front Neurol"},{"key":"10.1016\/j.seizure.2024.05.010_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/NDT.S181886","article-title":"Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles","volume":"15","author":"Yi","year":"2018","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.seizure.2024.05.010_bib0034","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2147\/NDT.S1655","article-title":"Monotherapy for partial epilepsy: focus on levetiracetam","volume":"4","author":"Gambardella","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.seizure.2024.05.010_bib0035","first-page":"CD011412","article-title":"Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data","volume":"4","author":"Nevitt","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.seizure.2024.05.010_bib0036","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.seizure.2008.11.001","article-title":"A prospective multi-centre open label study of the use of levetiracetam as add-on treatment in patients with epilepsy and intellectual disabilities","volume":"18","author":"Beavis","year":"2009","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2024.05.010_bib0037","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1365-2788.2007.00959.x","article-title":"Levetiracetam for the treatment of epilepsy among adults with intellectual disabilities","volume":"51","author":"Deb","year":"2007","journal-title":"J Intellect Disabil Res"},{"key":"10.1016\/j.seizure.2024.05.010_bib0038","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.yebeh.2003.12.005","article-title":"Levetiracetam in adult patients with and without learning disability: focus on behavioral adverse effects","volume":"5","author":"Brodtkorb","year":"2004","journal-title":"Epilepsy Behav\u202f: E&B"},{"key":"10.1016\/j.seizure.2024.05.010_bib0039","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1212\/01.WNL.0000133214.78602.B3","article-title":"A prospective analysis of the outcome of levetiracetam in clinical practice","volume":"63","author":"Nicolson","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2024.05.010_bib0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1528-1167.2011.03300.x","article-title":"Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study","volume":"53","author":"Delanty","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2024.05.010_bib0041","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.yebeh.2008.05.012","article-title":"Positive and negative psychotropic effects of levetiracetam","volume":"13","author":"Helmstaedter","year":"2008","journal-title":"Epilepsy Behav : E&B"},{"key":"10.1016\/j.seizure.2024.05.010_bib0042","unstructured":"NICE. National Institute for Health and Care Excellence. The epilepsies: the diagnosis and management of the epilepsies in adults and. vol. 137. 2012."},{"issue":"7","key":"10.1016\/j.seizure.2024.05.010_bib0043","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2165\/00002018-200124070-00004","article-title":"Behavioural effects of the new anticonvulsants","volume":"24","author":"Besag","year":"2001","journal-title":"Drug Saf."},{"key":"10.1016\/j.seizure.2024.05.010_bib0044","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/pds.4297","article-title":"Good practices for real-world data studies of treatment and\/or comparative effectiveness: recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making","volume":"26","author":"Berger","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131124001419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131124001419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T02:19:26Z","timestamp":1754014766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131124001419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":44,"alternative-id":["S1059131124001419"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2024.05.010","relation":{},"ISSN":["1059-1311"],"issn-type":[{"type":"print","value":"1059-1311"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and tolerability of levetiracetam in people with and without intellectual disabilities: A naturalistic case control study","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2024.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of British Epilepsy Association.","name":"copyright","label":"Copyright"}]}}